Skip to main content
. 2022 Jul 8;9:892159. doi: 10.3389/fmed.2022.892159

Table 2.

Summary of the demographic and clinical characteristics of the HTLV-1 and −2 cases observed during follow-up.

HTLV-1 Cases HTLV-2 Cases
( N :38/46) (N: 8/46)
AC SP AC
29/38 (76.3%) 9/38 (23.7%) 8/8 (100%)
Age (median) 44 years (IQR = 40–51) 46 years (IQR = 31–52) 46 (IQR = 40–52)
Sex 18/29 (62%) women 5/9 (55.5%) women 6/8 (75%) women
Birthplace 3 endemic area of Argentina (Salta, Santiago del Estero) 3 non-endemic area of Argentina. 1 endemic area of Argentina (Chaco)
17 non-endemic area of Argenttina 7 non-endemic area of Argentina
9 endemic area outside Argentina (Paraguay, Peru, Bolivia and Rep. Dominicana) 6 endemic area outside Argentina (Paraguay, Peru, Bolivia and Rep. Dominicana)
Coinfection 1 Chagas disease 2 HAM/TSP coinfected with HIV, HBV and HCV 1 HIV
1 HAM/TSP coinfected with TB and syphilis
1 HAM/TSP with Chagas disease
HTLV-1 pVL (median) 4.75 log10 HTLV-1 copies /106PBMCs 5.25 log10 HTLV-1 copies /106PBMCs Not Aplicable
(IQR 4.08-5.07) (IQR: 4.65-5.82)

AC, asymptomatic carriers; SP, symptomatic carriers; HTLV-1 pVL, HTLV-1 proviral load; TB, tuberculosis; HIV, human immunodeficiency virus; HCV, heaptitis C virus; HBV, hepatitis B virus; PBMC, peripheral mononuclear cells; IQR, interquartile range.